Banek CT, Bauer AJ, Gingery A, Gilbert JS. Timing of ischemic insult alters fetal growth trajectory, maternal angiogenic balance, and markers of renal oxidative stress in the pregnant rat. Am J Physiol Regul Integr Comp Physiol 303: R658 -R664, 2012. First published July 25, 2012 doi:10.1152/ajpregu.00250.2012.-Increased uterine artery resistance and angiogenic imbalance characterized by increased soluble fms-like tyrosine kinase-1 (sFlt-1) and decreased free vascular endothelial growth factor (VEGF) are often associated with placental insufficiency and preeclampsia but not synonymous with hypertension. We hypothesized chronic reductions in utero-placental perfusion (RUPP) for 5 days (d) during either mid-(d12-d17) or late (d14 -d19) gestation would have disparate effects on plasma sFlt-1 and VEGF levels and blood pressure. Five days of chronic RUPP was achieved by placement of silver clips on the abdominal aorta and ovarian arteries on either gestational d12 or d14. Arterial pressure was increased (P Ͻ 0.05) in RUPP vs. normal pregnant (NP) in both d17 (10%) and d19 (25%) groups, respectively. Circulating free VEGF was decreased (P Ͻ 0.05) and sFlt-1:VEGF ratio increased (P Ͻ 0.05) after 5 days of RUPP ending on d19 but not d17 compared with NP controls. Angiogenic imbalance, measured by an endothelial tube formation assay, was present in the d19 RUPP but not the d17 RUPP compared with age-matched NP rats. Five days of RUPP from days 14 to 19 decreased fetal and placental weights 10% (P Ͻ 0.01) compared with d19 NP controls. After 5 days of RUPP, from days 12 to 17 of pregnancy, fetal weights were 21% lighter (P Ͻ 0.01) compared with d17 NP controls, but placental weight was unchanged. These findings suggest that the timing during which placental insufficiency occurs may play an important role in determining the extent of alterations in angiogenic balance, fetal growth restriction, and the severity of placental ischemia-induced hypertension. preeclampsia; hypertension; intrauterine growth restriction; angiogenic balance PREECLAMPSIA AND HYPERTENSIVE disorders of pregnancy continue to be a major obstetric problem and a significant source of maternal and neonatal morbidity and mortality in pregnancies throughout the world (38, 42). Early delivery of the fetus is often indicated to prevent the progression of preeclampsia and to mitigate immediate maternal and fetal risk. Further, preeclampsia may account for up to 15% of all preterm births (37) and significantly contribute to the short-and long-term health burden generated by low-birth weight and/or preterm deliveries (13). Despite recent advancements that have identified a number of biomarkers that are associated with and may even help predict the onset of preeclampsia (5), numerous unanswered questions remain.Preeclampsia has historically been termed a "disease of many theories," and the wide range of risk factors and variability in the manifestations has been a persistent difficulty in the identification and treatment of patients. Recent clinical and experime...